Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Cronos Group Inc. (NASDAQ: CRON), a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, has been making headlines due to its impressive 20.5%..
For investors seeking opportunities in the dynamic biotechnology sector, Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) offers a compelling narrative with its innovative approach to tackling childhood and adult diseases. As..
As investors increasingly look toward biotechnology for promising growth opportunities, uniQure N.V. (NASDAQ: QURE) stands out with its noteworthy potential upside of 26.03%. Headquartered in Amsterdam, this innovative healthcare company..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is capturing significant attention in the biotechnology sector with its robust pipeline focused on rare diseases and a compelling potential upside of 117.43% as per..
Arcus Biosciences, Inc. (NASDAQ: RCUS) is capturing the attention of investors with its substantial potential upside of 86.37%, as highlighted by analysts’ average price target of $31.27. As a clinical-stage..
Arvinas, Inc. (NASDAQ: ARVN) is a name that has been capturing the attention of biotechnology investors, especially given its substantial potential upside of 96.51%. Operating within the healthcare sector and..
Definitive Healthcare Corp. (NASDAQ: DH), a leading provider of healthcare commercial intelligence through its SaaS platform, is capturing the attention of investors with its significant potential upside of 53.81%. Despite..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company headquartered in Warminster, Pennsylvania, stands out in the healthcare sector for its innovative approach to treating infectious diseases. With a market..
Immatics N.V. (NASDAQ: IMTX) is capturing significant attention in the biotech sector with its pioneering approach to cancer treatment through T cell redirecting immunotherapies. As a clinical-stage biopharmaceutical company headquartered..
For investors with an eye on the biotechnology sector, Relay Therapeutics, Inc. (NASDAQ: RLAY) presents an intriguing opportunity. With a current market capitalization of $1.17 billion, this clinical-stage precision medicines..
iRadimed Corporation (NASDAQ: IRMD), a pioneering player in the healthcare sector, has captured the attention of investors with its robust performance in the medical devices industry. Headquartered in Winter Springs,..
For investors eyeing the healthcare sector, particularly within the biotechnology industry, Tyra Biosciences, Inc. (NASDAQ: TYRA) presents a compelling opportunity. With a market capitalization of $752.56 million, this clinical-stage biotech..
Akso Health Group (NASDAQ: AHG), a dynamic player in the healthcare sector, has captured investor attention with its impressive 415.80% revenue growth. Operating at the intersection of medical distribution and..
Stoke Therapeutics, Inc. (NASDAQ: STOK) is making waves in the biotechnology sector with its innovative approach to treating severe genetic diseases. As a company that specializes in upregulating protein expression..
In the ever-evolving landscape of the biotechnology sector, Altimmune, Inc. (NASDAQ: ALT) stands out as a clinical-stage biopharmaceutical company with a compelling narrative and substantial upside potential. With a market..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing the attention of investors with its ambitious focus on developing treatments for rare diseases. Based in Deer Park, Illinois, Eton operates within the..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a dynamic player in the biotechnology sector, is garnering attention from investors due to its ambitious gene therapy programs targeting rare and severe diseases. The..
Investors seeking opportunities in the biotechnology sector might want to turn their attention to Upstream Bio, Inc. (NASDAQ: UPB), a promising clinical-stage biotech company. With a focus on developing treatments..
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company specializing in therapeutics for kidney diseases, presents an intriguing opportunity for investors seeking significant growth potential. With an impressive 148.32% anticipated upside,..
Butterfly Network, Inc. (NASDAQ: BFLY) is capturing the attention of investors with its innovative contributions to the medical devices industry. Founded in 2011 and headquartered in Burlington, Massachusetts, Butterfly Network..
